Cantargia AB (CANTA) NPV

Sell:4.06 SEKBuy:4.11 SEKPrice decreased0.10 SEK (2.30%)

Prices delayed by at least 15 minutes
Sell:4.06 SEK
Buy:4.11 SEK
Change:Price decreased0.10 SEK (2.30%)
Deal now
Prices delayed by at least 15 minutes
Sell:4.06 SEK
Buy:4.11 SEK
Change:Price decreased0.10 SEK (2.30%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open4.15 SEK
Previous close4.17 SEK
Market capSEK 1.04bn
P/E ratio6.88
Volume1,521,588
Dividend yield0.00%
EMS-

Company information

Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue248.61m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.